In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...

Experts say there’s no evidence GLP-1s can be absorbed through the skin — and these patches don’t contain the FDA-approved ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost ...

The popular weight-loss and diabetes drugs could play a significant role not only in disease prevention, but possibly in ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed by CVS Caremark.

A warning has now been issued after ‘GLP-1 weight-loss patches’ were spotted online amidst the surge in Mounjaro popularity.

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic and Mounjaro, the pharmaceutical company says.

New medicines have made weight loss easier than ever. But if you also want health and happiness, make these seven psychology ...

The appetite-suppressing medications reduce consumption of processed and sugary foods, creating new risks and opportunities.

Stopping anti-obesity medications leads to significant weight regain, starting as early as eight weeks and stabilizing by six ...

In 568 patients who underwent bariatric surgery, those who also used a GLP-1 receptor agonist during the preoperative and ...